April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Evaluation Of Compliance To Topical Therapy In POAG and PACG Patients in India
Author Affiliations & Notes
  • Tanuj Dada
    Ophthalmology, Glaucoma facility, Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India
  • Neha Chaturvedi
    Ophthalmology, Glaucoma facility, Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India
  • Tushar Agarwal
    Ophthalmology, Glaucoma facility, Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India
  • Anita Panda
    Ophthalmology, Glaucoma facility, Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India
  • Praveen Vashisht
    Ophthalmology, Glaucoma facility, Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India
  • GVS Murthy
    Ophthalmology, Glaucoma facility, Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India
  • Footnotes
    Commercial Relationships  Tanuj Dada, None; Neha Chaturvedi, None; Tushar Agarwal, None; Anita Panda, None; Praveen Vashisht, None; GVS Murthy, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 5034. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Tanuj Dada, Neha Chaturvedi, Tushar Agarwal, Anita Panda, Praveen Vashisht, GVS Murthy; Evaluation Of Compliance To Topical Therapy In POAG and PACG Patients in India. Invest. Ophthalmol. Vis. Sci. 2011;52(14):5034.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To evaluate the compliance to topical ocular hypotensive medications in patients of primary open angle glaucoma (POAG) and primary angle closure glaucoma (PACG) in the Indian population.

Methods: : A cross sectional study of 600 patients of POAG and PACG recruited from out patient services of a university hospital was performed using a semi structured questionnaire. Patients on bilateral therapy for a duration between 6 months to 3 years were included. Non-Compliance being defined as missing of 1 or more doses in the past one month. Factors leading to non-compliance were classified into four categories- situational, provider, regimen and system related.

Results: : Out of the 600 patients (300 POAG and 300 PACG) interviewed, 340(56.7%) were males, 260(43.3%) females. The mean age of patients was 60.2 + 11.6 years . Three hundred and sixty patients (60%) were found to be non-compliant, including 160 with POAG and 200 with PACG (p = 0.01). Fifty patients (14%) reported on missing medication for more than one week . The factors leading to non-compliance were - Situational (510 patients,85%), Regimen related (60 patients,10%), Provider related (18 patients,3%), System related (12 patients,2%). The three most common situational obstacles to compliance were forgetfulness (45%), travel (35%) and unable to purchase drug due to lack of money (15%). Two hundred and forty patients (43.3%) were financially dependent on a care taker for their medications . Out of the 290 literate patients 170 (58.6%) were compliant while out of the 310 illiterate patients, only 60 patients (19.34%) were complaint [p = 0.001 ].

Conclusions: : High rates of non-compliance were seen in the Indian population with 6 out of 10 patients missing medications . The non compliance rates were higher in PACG as compared to POAG patients and in illliterate versus literate patients. Situational factors were implicated as the cause for non-compliance in majority of the patients.

Keywords: clinical (human) or epidemiologic studies: health care delivery/economics/manpower • clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×